Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2010
12/02/2010US20100303905 Orally Disintegrating Tablet Compositions of Lamotrigine
12/02/2010US20100303904 Tablet with remedial composition and methods for treating medical disorders and ailments
12/02/2010US20100303903 Methods of enhancing selective serotonin reuptake inhibitor effects in mammals
12/02/2010US20100303902 Self-emulsifying pharmaceutical compositions of rhein or diacerein
12/02/2010US20100303901 Oral delivery of proteins and peptides
12/02/2010US20100303900 Preparation of injectable suspensions having improved injectability
12/02/2010US20100303899 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
12/02/2010US20100303898 Collagen dispersion and method of producing same
12/02/2010US20100303897 Novel addl receptor polypeptides, polynucleotides and host cells for recombinant production
12/02/2010US20100303896 5beta, 14beta-androstane derivatives useful for the treatment of restenosis after angioplastic or endoartherectomy and diseases due to organ fibrosis
12/02/2010US20100303895 Fixed drug ratios for treatment of hematopoietic cancers and proliferative disorders
12/02/2010US20100303894 Pox viridae treatment
12/02/2010US20100303893 Novel compound for treatment of tumor
12/02/2010US20100303892 Transdermal therapeutic system containing elongate hollow bodies
12/02/2010US20100303891 Supramacromolecular polymer complexes providing controlled nitric oxide release for healing wounds
12/02/2010US20100303888 Composition for enhancing bone formation
12/02/2010US20100303887 DHA and PEDF, a Therapeutic Composition for Nerve and Retinal Pigment Epithelial Cells
12/02/2010US20100303881 Therapeutic Electrospun Fiber Compositions
12/02/2010US20100303877 Controlled Release Hydrogel Films
12/02/2010US20100303874 Anisotropic self-assembly of nanoparticles in composites
12/02/2010US20100303871 Compositions and methods for modulating cellular membrane-mediated intracellular signal transduction
12/02/2010US20100303870 Methods of treating non-alcoholic steatohepatitis (nash) using cysteamine products
12/02/2010US20100303869 Process for Producing Antimicrobial-Coated Superabsorbents
12/02/2010US20100303737 Tooth-Cleaning Formulation
12/02/2010US20100303736 Anti-il-9 antibody formulations and uses thereof
12/02/2010US20100303735 Method and arrangement for forming variable color pharmaceutical products
12/02/2010US20100303730 Methods of making iron-containing nanoparticles
12/02/2010US20100303723 Drug delivery systems using fc fragments
12/02/2010US20100303718 Stabilized Uncoated Particles of Reversed Liquid Crystalline Phase Materials
12/02/2010US20100303717 Stabilized Uncoated Particles of Reversed Liquid Crystalline Phase Materials Cross Reference to Related Applications
12/02/2010US20100300530 Flagella as a Biological Material for Nanostructured Devices
12/02/2010US20100300440 Dry powder inhaler system
12/02/2010US20100300433 Substrates for Enhancing Purity or Yield of Compounds Forming a Condensation Aerosol
12/02/2010DE102009022895A1 Substituierte Piperidine Substituted piperidines
12/02/2010CA2763941A1 Compositions, methods & systems for respiratory delivery of two or more active agents
12/02/2010CA2763939A1 Compositions for pulmonary delivery of long-acting muscarinic antagonists and long-acting b2 adrenergic receptor agonists and associated methods and systems
12/02/2010CA2763936A1 Compositions for respiratory delivery of active agents and associated methods and systems
12/02/2010CA2763541A1 Method for preparing hollow particles, and uses thereof
12/02/2010CA2763539A1 Controlled-release floating pharmaceutical compositions
12/02/2010CA2763465A1 A poorly soluble drug containing microsphere with improved bioavailability and method of preparing the same
12/02/2010CA2763456A1 Reduction of flake-like aggregation in nanoparticulate active agent compositions
12/02/2010CA2763320A1 Oral medical composition and oral medical capsule enclosing the same
12/02/2010CA2763139A1 Functional amphiphilic molecule or macromolecule formulations with multiple compartments
12/02/2010CA2762653A1 Immunomodulatory agent-polymeric compounds
12/02/2010CA2762650A1 Targeted synthetic nanocarriers with ph sensitive release of immunomodulatory agents
12/02/2010CA2762647A1 Nanocarriers possessing components with different rates of release
12/02/2010CA2761904A1 Treatment of tissue adhesion
12/02/2010CA2761903A1 Dry powder fibrin sealant
12/02/2010CA2761744A1 Methods for administration and formulations for the treatment of regional adipose tissue
12/02/2010CA2760199A1 Composition
12/01/2010EP2255831A1 Liposome based diepitope constructs
12/01/2010EP2255829A2 Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising EP4 agonist as active ingredient
12/01/2010EP2255821A1 Micro/nanoparticle obtained from lipid-containing marine organisms for use in pharmaceutics and cosmetics
12/01/2010EP2255812A1 Methods and compositions for reducing neurodegeneration in amyotrophic lateral sclerosis
12/01/2010EP2255810A1 Pharmaceutical forms comprising vardenafil and having a controlled bioavailability
12/01/2010EP2255809A1 Medicated patch
12/01/2010EP2255806A2 Fentanyl composition for nasal administration
12/01/2010EP2255803A1 Oral galenic formulation including ketorolac and b-complex vitamins, in which vitamin b6 is in an outer layer separated from the rest of the active principles
12/01/2010EP2255802A1 Adhesive skin patch and packaged product
12/01/2010EP2255797A2 Composite preparation
12/01/2010EP2255796A2 Pharmaceutical preparation
12/01/2010EP2255795A1 Immediate release dosage form comprising shell having openings therein
12/01/2010EP2255794A1 Enteric coating
12/01/2010EP2255793A1 Pharmaceutical composition comprising tamsulosin
12/01/2010EP2255792A1 Pharmaceutical compositions for N-[2-(Diethylamino)ethyl]5-[(fluoro-1,2-dihydro-2-oxo-3H-indole-3-ylidene) methyl]-2,4-dimenthyl-1H-pyrrole-3-carboxamide
12/01/2010EP2255791A1 Extended release pharmaceutical composition comprising metoprolol succinate
12/01/2010EP2255790A1 Liposome composition comprising naproxen, and a method of obtaining same
12/01/2010EP2255789A1 Virosome-like-particles
12/01/2010EP2255788A1 Liposome for delivery to posterior segment of eye and pharmaceutical composition for disease in posterior segment of eye
12/01/2010EP2255787A1 Synthetic glycolipid-containing liposomes
12/01/2010EP2255786A1 Self-microemulsifying mitotane composition
12/01/2010EP2255785A2 Stable emulsion composition
12/01/2010EP2255784A1 Composition for easing human childbirth
12/01/2010EP2255783A2 Azelaic acid gel, and a method of obtaining same
12/01/2010EP2255745A1 System for concurrent tooth repositioning and substance delivery
12/01/2010EP2255677A2 Suclarose Formulation and Production Process Thereof
12/01/2010EP2255661A2 Enteric formulations of proanthocyanidin polymer antidiarrheal compositions
12/01/2010EP2254952A2 Pharmaceutical dye extracted from cranberry with high proanthocyanidin a concentration
12/01/2010EP2254857A1 Compositions and methods for treating ophthalmic diseases
12/01/2010EP2254831A2 Method for manufacturing mesoporous materials, materials so produced and use of mesoporous materials.
12/01/2010EP2254651A2 Local embolization using thermosensitive polymers
12/01/2010EP2254590A2 Methods and compositions for oral administration of insulin
12/01/2010EP2254582A2 Methods of treating viral infections
12/01/2010EP2254567A2 Novel use of zinc n-acetyltaurinate
12/01/2010EP2254562A1 Nanosuspension with antifungal medication to be administered via inhalation with improved impurity profile and safety
12/01/2010EP2254561A2 Abuse deterrent transdermal formulations of opiate agonists and agonist-antagonists
12/01/2010EP2254560A1 Preparation of nanoparticles by using a vibrating nozzle device
12/01/2010EP2254559A1 Composition for sustained release delivery of proteins or peptides
12/01/2010EP2254558A1 Orally disintegrating tablets with speckled appearance
12/01/2010EP2254557A1 Methods to inhibit tumor cell growth by using proton pump inhibitors
12/01/2010EP2254556A2 Orally-disintegrating solid preparation
12/01/2010EP2254555A2 Solubility-enhanced forms of aprepitant and pharmaceutical compositions thereof
12/01/2010EP2254554A1 Sugar glassified virus like particles (vlps)
12/01/2010EP2254553A1 Abuse resistant melt extruded formulation having reduced alcohol interaction
12/01/2010EP2254552A1 Long-term stable pharmaceutical preparation having the active ingredient glycerol trinitrate
12/01/2010EP2254551A2 Sterilized sucralfate gel
12/01/2010EP2254550A1 Pharmaceutical composition with gelling properties containing a tyrosine derivative
12/01/2010EP2254549A2 Aqueous pharmaceutical compositions containing borate-polyol complexes
12/01/2010EP2254546A2 Topical compositions and methods for whitening skin
12/01/2010EP2186509B1 Propofol transparent anaesthetic solution with low venous irritation
1 ... 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 ... 2991